MedKoo Cat#: 530788 | Name: Psychosine-3'-sulfate ester

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Psychosine-3'-sulfate ester is a bioactive chemical.

Chemical Structure

Psychosine-3'-sulfate ester
Psychosine-3'-sulfate ester
CAS#70005-46-8

Theoretical Analysis

MedKoo Cat#: 530788

Name: Psychosine-3'-sulfate ester

CAS#: 70005-46-8

Chemical Formula: C24H46NNaO10S

Exact Mass: 563.2740

Molecular Weight: 563.68

Elemental Analysis: C, 51.14; H, 8.23; N, 2.48; Na, 4.08; O, 28.38; S, 5.69

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Psychosine-3'-sulfate ester
IUPAC/Chemical Name
beta-D-Galactopyranoside, 2-amino-3-hydroxy-4-octadecenyl, 3-(hydrogen sulfate), monosodium salt, (R-(R*,S*-(E)))-
InChi Key
YNZCBVKPSQVVAL-BIFWVYATSA-N
InChi Code
InChI=1S/C24H46NO10S.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(27)18(25)17-33-24-22(29)23(35-36(30,31)32)21(28)20(16-26)34-24;/h14-15,18-24,26-28H,2-13,16-17,25H2,1H3,(H,30,31,32);/q-1;+1/b15-14+;/t18-,19+,20+,21-,22+,23-,24+;/m0./s1
SMILES Code
[O-][C@H]([C@@H](OS(=O)(O)=O)[C@H]([C@@H](CO)O1)O)[C@@H]1OC[C@H](N)[C@H](O)/C=C/CCCCCCCCCCCCC.[Na+]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 563.68 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Yegneswaran S, Banerjee Y, Fernández JA, Deguchi H, Griffin JH. Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex. PLoS One. 2015 Aug 11;10(8):e0135025. doi: 10.1371/journal.pone.0135025. eCollection 2015. PubMed PMID: 26263376; PubMed Central PMCID: PMC4532512. 2: Mirzaian M, Kramer G, Poorthuis BJ. Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry. J Lipid Res. 2015 Apr;56(4):936-43. doi: 10.1194/jlr.M057232. Epub 2015 Jan 27. PubMed PMID: 25632048; PubMed Central PMCID: PMC4373750. 3: Fuss IJ, Joshi B, Yang Z, Degheidy H, Fichtner-Feigl S, de Souza H, Rieder F, Scaldaferri F, Schirbel A, Scarpa M, West G, Yi C, Xu L, Leland P, Yao M, Mannon P, Puri RK, Fiocchi C, Strober W. IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis. Gut. 2014 Nov;63(11):1728-36. doi: 10.1136/gutjnl-2013-305671. Epub 2014 Feb 10. PubMed PMID: 24515806; PubMed Central PMCID: PMC4782805. 4: Blomqvist M, Gieselmann V, Månsson JE. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice. Lipids Health Dis. 2011 Feb 7;10:28. doi: 10.1186/1476-511X-10-28. PubMed PMID: 21299873; PubMed Central PMCID: PMC3041674. 5: Yamamoto H, Naito Y, Okano M, Kanazawa T, Takematsu H, Kozutsumi Y. Sphingosylphosphorylcholine and lysosulfatide have inverse regulatory functions in monocytic cell differentiation into macrophages. Arch Biochem Biophys. 2011 Feb 1;506(1):83-91. doi: 10.1016/j.abb.2010.11.004. Epub 2010 Nov 21. PubMed PMID: 21081108. 6: Banerjee Y, Taranikanti V, Bayoumi R. Triglyceride-mediated pathways and coronary heart disease. Lancet. 2010 Sep 18;376(9745):956; author reply 957-8. doi: 10.1016/S0140-6736(10)61447-X. PubMed PMID: 20851256. 7: Hans M, Pusch A, Dai L, Racké K, Swandulla D, Gieselmann V, Kappler J. Lysosulfatide regulates the motility of a neural precursor cell line via calcium-mediated process collapse. Neurochem Res. 2009 Mar;34(3):508-17. doi: 10.1007/s11064-008-9813-7. Epub 2008 Aug 22. PubMed PMID: 18719997. 8: Li G, Hu R, Kamijo Y, Nakajima T, Aoyama T, Inoue T, Node K, Kannagi R, Kyogashima M, Hara A. Establishment of a quantitative, qualitative, and high-throughput analysis of sulfatides from small amounts of sera by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Anal Biochem. 2007 Mar 1;362(1):1-7. Epub 2006 Dec 20. PubMed PMID: 17254536. 9: Nofer JR, Levkau B, Wolinska I, Junker R, Fobker M, von Eckardstein A, Seedorf U, Assmann G. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem. 2001 Sep 14;276(37):34480-5. Epub 2001 Jun 29. PubMed PMID: 11432865. 10: Nofer JR, Fobker M, Höbbel G, Voss R, Wolinska I, Tepel M, Zidek W, Junker R, Seedorf U, von Eckardstein A, Assmann G, Walter M. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry. 2000 Dec 12;39(49):15199-207. PubMed PMID: 11106499. 11: Kanazawa T, Nakamura S, Momoi M, Yamaji T, Takematsu H, Yano H, Sabe H, Yamamoto A, Kawasaki T, Kozutsumi Y. Inhibition of cytokinesis by a lipid metabolite, psychosine. J Cell Biol. 2000 May 15;149(4):943-50. PubMed PMID: 10811833; PubMed Central PMCID: PMC2174564. 12: Sugiyama E, Hara A, Uemura K. A quantitative analysis of serum sulfatide by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction. Anal Biochem. 1999 Oct 1;274(1):90-7. PubMed PMID: 10527500. 13: Masson M, Li WX, Fluharty AL, Beaucourt JP, Turpin JC, Baumann N. Improved synthesis of [1-14C]acyl-sphingosine-galactose-3-sulfate (sulfatide) for diagnosis of metachromatic leukodystrophy: usefulness of radioscanning. Clin Chim Acta. 1991 Sep 30;201(3):157-68. PubMed PMID: 1684534. 14: Toda K, Kobayashi T, Goto I, Ohno K, Eto Y, Inui K, Okada S. Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy. J Neurochem. 1990 Nov;55(5):1585-91. PubMed PMID: 1976756. 15: Sugiyama E, Uemura K, Hara A, Taketomi T. Effects of various lysosphingolipids on cell growth, morphology and lipid composition in three neuroblastoma cell lines. Biochem Biophys Res Commun. 1990 Jun 15;169(2):673-9. PubMed PMID: 2357225. 16: Taketomi T, Hara A, Kutsukake Y, Sugiyama E. New approach for characterization of lysosulfatide by TLC, fast atom bombardment mass spectrometry and NMR spectroscopy. J Biochem. 1990 May;107(5):680-4. PubMed PMID: 2398033. 17: Rosengren B, Fredman P, Månsson JE, Svennerholm L. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain. J Neurochem. 1989 Apr;52(4):1035-41. PubMed PMID: 2926387. 18: Toda K, Kobayashi T, Goto I, Kurokawa T, Ogomori K. Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy. Biochem Biophys Res Commun. 1989 Mar 15;159(2):605-11. PubMed PMID: 2539117. 19: Nonaka G, Kishimoto Y, Seyama Y, Yamakawa T. Formation of lysosulfatide, 3',6'-anhydropsychosine, ceramide, and sphingosine by saponification of cerebroside sulfate. Effect of the sulfate group on the hydrolysis. J Biochem. 1979 Feb;85(2):511-8. PubMed PMID: 422543.